title: Audit of three antimuscarinic drugs for managing retained secretions.
authors.affiliation: Hayward House Macmillan Specialist Palliative Care Unit, Nottingham City Hospital NHS Trust, UK.
authors.forename: A
authors.initials: A
authors.lastname: Hughes
authors.forename: A
authors.initials: A
authors.lastname: Wilcock
authors.forename: R
authors.initials: R
authors.lastname: Corcoran
authors.forename: V
authors.initials: V
authors.lastname: Lucas
authors.forename: A
authors.initials: A
authors.lastname: King
mesh_terms: D012634:Bodily Secretions / Q000187:drug effects*; D006024:Glycopyrrolate / Q000627:therapeutic use*; D006801:Humans; D008485:Medical Audit; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D010166:Palliative Care / Q000379:methods; D017410:Practice Guidelines as Topic / Q000592:standards*; D011446:Prospective Studies; D012601:Scopolamine / Q000627:therapeutic use*; D013727:Terminal Care / Q000379:methods*
chemical_list: D018727:Muscarinic Antagonists; D012601:Scopolamine; D006024:Glycopyrrolate